A study from Watson School of Biological Sciences shows that SRSF1 is a critical transcriptional target of c-MYC. This study was published in the Feb 20, 2012 Cell Rep by Prof. Dr Krainer AR & Das, Watson School of Biological Sciences, USA.
On the foundation of this interesting finding, Dr L Boominathan, Director-cum-chief Scientist of GBMD, reports here that: Molecularly targeted therapy for cancer: RREB [Ras responsive element (RRE) binding protein] increases the expression of SRSF1 via up regulation of its target gene. This data suggest that RREB, by increasing the expression of SRSF1, it will increase the expression of a number of oncogenic mRNAs in cancer cells.
Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Web: http://genomediscovery.org
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
To cite: Boominathan, Molecularly targeted therapy for cancer: RREB [Ras responsive element (RRE) binding protein] increases the expression of SRSF1 via up regulation of its target gene, 13/May/2014, 6.01 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
